Olav Lanes
Direttore Tecnico/Scientifico/R&S presso ARCTICZYMES TECHNOLOGIES ASA
Patrimonio netto: 4 875 $ in data 31/05/2024
Provenienza dei contatti di primo grado di Olav Lanes
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Medical Specialties | 26 | |
University of Tromso
5
| College/University | Other Consumer Services | 5 |
ArcticZymes AS
 ArcticZymes AS Medical SpecialtiesHealth Technology Part of ArcticZymes Technologies ASA, ArcticZymes AS is a Norwegian company that manufactures diagnostic substances. The company is based in Tromsø, Norway. Jethro Holter has been the CEO of the company since 2015.
2
| Subsidiary | Medical Specialties | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Olav Lanes tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ALERE INC | Medical Specialties | Corporate Officer/Principal | |
| PATRYS LIMITED | Pharmaceuticals: Major | Chief Executive Officer | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member Director/Board Member | |
| RECKITT BENCKISER GROUP PLC | Household/Personal Care | Sales & Marketing | |
| University of Bath | College/University | Masters Business Admin | |
| AXIS-SHIELD LTD | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Royal Pharmaceutical Society of Great Britain
 Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Undergraduate Degree | |
| NEL ASA | Industrial Machinery | Director/Board Member | |
| University of London | College/University | Doctorate Degree | |
DCC Healthcare Ltd.
 DCC Healthcare Ltd. Medical DistributorsDistribution Services DCC Healthcare Ltd. supplies medical, surgical, and laboratory equipment and pharmaceuticals to the Irish healthcare sector. The company is headquartered in Stillorgan, Ireland. | Medical Distributors | Chief Executive Officer | |
Unomedical A/S
 Unomedical A/S Medical SpecialtiesHealth Technology Unomedical A/S manufactures and distributes medical devices. It offers catheters, surgical aids, electrocardiography electrodes, general nursing products, drainage bags, wound care products, and infusion devices. The company is headquartered in Lejre, Denmark. | Medical Specialties | Chief Executive Officer | |
| University of Oslo | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Norwegian University of Science & Technology | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Masters Business Admin | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Operating Officer | |
Sarsia Venture Management AS
 Sarsia Venture Management AS Investment ManagersFinance Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region. | Investment Managers | Private Equity Investor | |
Aenova Holding GmbH
 Aenova Holding GmbH Medical DistributorsDistribution Services Aenova Holding GmbH provides supplies to the pharmaceutical and healthcare industries. The firm develops, produces, and markets solid dosage products such as soft and hard capsules, tablets, film-coated tablets, and effervescent tablets. Its services include production, supply chain management, packaging, support and analytics. The company was founded in 2008 and is headquartered in Starnberg, Germany. | Medical Distributors | Chief Executive Officer | |
SPD Swiss Precision Diagnostics GmbH
 SPD Swiss Precision Diagnostics GmbH Medical SpecialtiesHealth Technology SPD Swiss Precision Diagnostics GmbH supplies home pregnancy and fertility/ovulation tests. Its products are designed to give women a better understanding of their own reproductive health and invaluable guidance in their family planning. The company was founded in 2007 and is headquartered in Petit-Lancy, Switzerland. | Medical Specialties | Chairman | |
| LYTIX BIOPHARMA | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Uni Targeting Research AS
 Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Biotechnology | Chairman | |
siRNAsense AS
 siRNAsense AS Miscellaneous Commercial ServicesCommercial Services siRNAsense AS focuses on developing pipeline drugs. Its sources projects include Biotechnology Centre of Oslo, Centre for Molecular Biology and Neuroscience, Rikshospitalet-Radiumhospitalet HF and University of Oslo. The company was founded in December 2004 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Chairman | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
| SERODUS ASA | Biotechnology | Director/Board Member | |
| Radiumhospitalets Parkeringsselskap AS | Corporate Officer/Principal | ||
Nextera AS
 Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Chairman | |
Catalent Pharma Solutions Ltd.
 Catalent Pharma Solutions Ltd. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions Ltd. develops and markets drug delivery systems. The company is headquartered in Swindon, GB. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Axis-Shield AS | Corporate Officer/Principal | ||
Axis Shield PoC AS
 Axis Shield PoC AS Medical SpecialtiesHealth Technology Part of Abbott Laboratories, Axis Shield PoC AS is a Norwegian company that manufactures diagnostic testing devices. The company is based in Oslo, Norway. Kjersti Grimsrud has been the CEO of the company since 1987. | Medical Specialties | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Eli Lilly Norge AS
 Eli Lilly Norge AS Medical DistributorsDistribution Services Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway. | Medical Distributors | Corporate Officer/Principal | |
| BERGENBIO ASA | Pharmaceuticals: Major | Chief Executive Officer | |
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Pharmaceuticals: Major | Founder | |
| Noregs forskingsråd | General Government | Director/Board Member | |
Helmholtz Zentrum München
 Helmholtz Zentrum München Miscellaneous Commercial ServicesCommercial Services Helmholtz Zentrum München is a research center located in Munich, Germany. The center's mission is to discover personalized medical solutions for the prevention and therapy of environmentally triggered diseases and promote a healthier society in a rapidly changing world. Helmholtz Zentrum München investigates the interaction of genetics, environmental factors, and lifestyle to achieve this goal. The center is a member of the Helmholtz Association, the largest scientific organization with more than 40,000 employees at 19 research centers. Helmholtz Zentrum München has approximately 2,500 staff members and is headquartered in Neuherberg in the north of Munich. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Norwegian Bioindustry Association | Director/Board Member | ||
Otivio AS
 Otivio AS Medical SpecialtiesHealth Technology Otivio AS manufactures non-invasive medical devices. The private company is based in Oslo, Norway. | Medical Specialties | Director/Board Member | |
| GENETIC ANALYSIS | Medical Specialties | Chairman Chairman | |
Balter Medical AS
 Balter Medical AS Medical SpecialtiesHealth Technology Balter Medical AS engages in the development and commercialization of biomedical technology. Its product assists healthcare professionals in diagnosing patients with Melanoma. The company was founded by Jakob Johan Stamnes and Knut Stamnes on December 13, 2000 and is headquartered in Bergen, Norway. | Medical Specialties | Director/Board Member | |
| Euromed AS | Chief Tech/Sci/R&D Officer | ||
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| CONVATEC GROUP PLC | Medical Specialties | Corporate Officer/Principal | |
| GENTIAN DIAGNOSTICS | Medical Specialties | Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer | |
Biotec BetaGlucans AS
 Biotec BetaGlucans AS Pharmaceuticals: MajorHealth Technology Part of Lallemand, Inc., Biotec BetaGlucans AS is a Norwegian company that specializes in developing M-Gard®, an immunomodulator that enhances the body's defense mechanisms against pathogens. The company is based in Tromsø, Norway. The technology behind M-Gard® has been successfully developed for alternative indications and applications, including nutraceuticals, wound care, and immunotherapy. The CEO of the company is Jethro Holter. Biotec BetaGlucans was acquired by Danstar Ferment AG from ArcticZymes Technologies ASA on December 31, 2020 for $7.93 million. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member | |
| Alertis AS | Director/Board Member | ||
| Afiew AS | Director/Board Member |
Statistiche
Distribuzione geografica
| Norvegia | 32 |
| Regno Unito | 10 |
| Germania | 5 |
| Stati Uniti | 2 |
| Australia | 2 |
Settori
| Health Technology | 25 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 4 |
| Distribution Services | 4 |
Posizioni
| Director/Board Member | 85 |
| Chairman | 39 |
| Corporate Officer/Principal | 38 |
| Chief Executive Officer | 36 |
| Independent Dir/Board Member | 14 |
Contatti più connessi
| Insiders | |
|---|---|
| Hilde Hermansen Steineger | 24 |
| Erik Thorsen | 19 |
| Svein Wilhelm Faye Lien | 18 |
| Ingrid Alfheim | 15 |
| Martin Hunt | 15 |
| Richard Stuart Godfrey | 15 |
| Christian Jørgensen | 14 |
| Svein Arild Mathisen | 14 |
| Arne Reinemo | 13 |
| Dino DiCamillo | 12 |
| Kjersti Grimsrud | 10 |
| Lars Kåre Viksmoen | 9 |
| Børge Sørvoll | 6 |
| Marie Roskrow | 6 |
| Jethro Holter | 6 |
- Borsa valori
- Insiders
- Olav Lanes
- Connessioni Società
